U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H16ClNO2S.BrH
Molecular Weight 402.734
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOPIDOGREL HYDROBROMIDE

SMILES

Br.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl

InChI

InChIKey=QKLHYWAZTQRTBR-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.BrH/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;/h2-5,7,9,15H,6,8,10H2,1H3;1H/t15-;/m0./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
CLOPIDOGREL HYDROBROMIDE
WHO-DD  
Common Name English
CLOPIDOGREL TEVA PHARMA B.V.
Brand Name English
Clopidogrel hydrobromide [WHO-DD]
Common Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, HYDROBROMIDE (1:1), (.ALPHA.S)-
Common Name English
(S)-(+)-CLOPIDOGREL HYDROBROMIDE
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA B.V. (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA B.V. (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)+
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA B.V. (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL TEVA PHARMA B.V. (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
Code System Code Type Description
FDA UNII
96AAH2D689
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
PUBCHEM
11304210
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
CAS
120202-67-7
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
EVMPD
SUB76368
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
SMS_ID
100000137773
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
EPA CompTox
DTXSID00152735
Created by admin on Fri Dec 15 20:23:09 UTC 2023 , Edited by admin on Fri Dec 15 20:23:09 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of CLOPIDOGREL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966